G Protein-Coupled Receptor Kinase 2 Promotes Flaviviridae Entry and Replication

PLoS Neglected Tropical Diseases

Volumn 6, Issue 9, 2012, Pages

  Le Sommer, Caroline ^a   Barrows, Nicholas J ^a,b   Bradrick, Shelton S ^a   Pearson, James L ^a   Garcia Blanco, Mariano A ^a,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR KINASE 2; HOST FACTOR; SMALL INTERFERING RNA; VIRUS RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DENGUE VIRUS; ELECTROPORATION; FLAVIVIRUS; FLAVIVIRUS INFECTION; HEPATITIS C VIRUS; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LIFE CYCLE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SYNTHESIS; VIRUS ENTRY; VIRUS REPLICATION; WESTERN BLOTTING; YELLOW FEVER FLAVIVIRUS;

ANIMALS; CELL LINE; FLAVIVIRIDAE; G-PROTEIN-COUPLED RECEPTOR KINASE 2; GENE SILENCING; GENETIC TESTING; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE; MICE, KNOCKOUT; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 84866952384     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001820     Document Type: Article

References (49)

1. WHO (2005) Available: http://www.who.int/csr/disease/yellowfev/trends/en/index.html. Accessed 2011 Jun 10.
2. Weaver SC, Reisen WK, (2010) Present and future arboviral threats. Antiviral Res 85: 328-345.
3. Barrett AD, Teuwen DE, (2009) Yellow fever vaccine- how does it work and why do rare cases of serious adverse events take place? Curr Opin Immunol 21: 308-313.
4. Barrett PN, Schober-Bendixen S, Ehrlich HJ, (2003) History of TBE vaccines. Vaccine 21Suppl 1: S41-49.
5. Halstead SB, Thomas SJ, (2010) Japanese encephalitis: new options for active immunization. Clin Infect Dis 50: 1155-1164.
6. Theiler M, Smith HH, (1937) The Use of Yellow Fever Virus Modified by in Vitro Cultivation for Human Immunization. J Exp Med 65: 787-800.
7. Gardner CL, Ryman KD, (2010) Yellow fever: a reemerging threat. Clin Lab Med 30: 237-260.
8. Sessions OM, Barrows NJ, Souza-Neto JA, Robinson TJ, Hershey CL, et al. (2009) Discovery of insect and human dengue virus host factors. Nature 458: 1047-1050.
9. Krishnan MN, Ng A, Sukumaran B, Gilfoy FD, Uchil PD, et al. (2008) RNA interference screen for human genes associated with West Nile virus infection. Nature 455: 242-245.
10. Premont RT, Inglese J, Lefkowitz RJ, (1995) Protein kinases that phosphorylate activated G protein-coupled receptors. FASEB J 9: 175-182.
11. Reiter E, Lefkowitz RJ, (2006) GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling. Trends Endocrinol Metab 17: 159-165.
12. Penela P, Murga C, Ribas C, Lafarga V, Mayor F Jr, (2010) The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets. Br J Pharmacol 160: 821-832.
13. Ribas C, Penela P, Murga C, Salcedo A, Garcia-Hoz C, et al. (2007) The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling. Biochim Biophys Acta 1768: 913-922.
14. Clyde K, Barrera J, Harris E, (2008) The capsid-coding region hairpin element (cHP) is a critical determinant of dengue virus and West Nile virus RNA synthesis. Virology 379: 314-323.
15. Katzenberger RJ, Marengo MS, Wassarman DA, (2006) ATM and ATR pathways signal alternative splicing of Drosophila TAF1 pre-mRNA in response to DNA damage. Mol Cell Biol 26: 9256-9267.
16. Kato T, Date T, Murayama A, Morikawa K, Akazawa D, et al. (2006) Cell culture and infection system for hepatitis C virus. Nat Protoc 1: 2334-2339.
17. Barrows NJ, Le Sommer C, Garcia-Blanco MA, Pearson JL, (2010) Factors affecting reproducibility between genome-scale siRNA-based screens. J Biomol Screen 15: 735-747.
18. Diamond MS, Harris E, (2001) Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism. Virology 289: 297-311.
19. Edgil D, Diamond MS, Holden KL, Paranjape SM, Harris E, (2003) Translation efficiency determines differences in cellular infection among dengue virus type 2 strains. Virology 317: 275-290.
20. Santa Maria Guerra F (2008) West Nile Virus Versus the Host Cell: Identification of Host Factors that Modulate Infection. Unpublished doctoral dissertation, University of Texas, Medical Branch at Galveston, Texas.
21. Andoh T, Kawamata H, Umatake M, Terasawa K, Takegami T, et al. (1998) Effect of bafilomycin A1 on the growth of Japanese encephalitis virus in Vero cells. J Neurovirol 4: 627-631.
22. Nawa M, (1997) Japanese encephalitis virus infection in Vero cells: the involvement of intracellular acidic vesicles in the early phase of viral infection was observed with the treatment of a specific vacuolar type H+-ATPase inhibitor, bafilomycin A1. Microbiol Immunol 41: 537-543.
23. Nawa M, (1998) Effects of bafilomycin A1 on Japanese encephalitis virus in C6/36 mosquito cells. Arch Virol 143: 1555-1568.
24. Benovic JL, Mayor F Jr, Staniszewski C, Lefkowitz RJ, Caron MG, (1987) Purification and characterization of the beta-adrenergic receptor kinase. J Biol Chem 262: 9026-9032.
25. Premont RT, Macrae AD, Stoffel RH, Chung N, Pitcher JA, et al. (1996) Characterization of the G protein-coupled receptor kinase GRK4. Identification of four splice variants. J Biol Chem 271: 6403-6410.
26. Lupberger J, Zeisel MB, Xiao F, Thumann C, Fofana I, et al. (2011) EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat Med 17: 589-595.
27. Blight KJ, McKeating JA, Rice CM, (2002) Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 76: 13001-13014.
28. Kato T, Date T, Miyamoto M, Furusaka A, Tokushige K, et al. (2003) Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125: 1808-1817.
29. Chu JJ, Ng ML, (2004) Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway. J Virol 78: 10543-10555.
30. van der Schaar HM, Rust MJ, Chen C, van der Ende-Metselaar H, Wilschut J, et al. (2008) Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog 4: e1000244.
31. Shenoy SK, Lefkowitz RJ, (2003) Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem J 375: 503-515.
32. Kohout TA, Lin FS, Perry SJ, Conner DA, Lefkowitz RJ, (2001) beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. Proc Natl Acad Sci U S A 98: 1601-1606.
33. Echeverri CJ, Beachy PA, Baum B, Boutros M, Buchholz F, et al. (2006) Minimizing the risk of reporting false positives in large-scale RNAi screens. Nat Methods 3: 777-779.
34. Jiang M, Instrell R, Saunders B, Berven H, Howell M, (2011) Tales from an academic RNAi screening facility; FAQs. Brief Funct Genomics.
35. Duan X, Lu X, Li J, Liu Y, (2008) Novel binding between pre-membrane protein and vacuolar ATPase is required for efficient dengue virus secretion. Biochem Biophys Res Commun 373: 319-324.
36. Evron T, Daigle TL, Caron MG, (2012) GRK2: multiple roles beyond G protein-coupled receptor desensitization. Trends Pharmacol Sci.
37. Gurevich EV, Tesmer JJ, Mushegian A, Gurevich VV, (2012) G protein-coupled receptor kinases: more than just kinases and not only for GPCRs. Pharmacol Ther 133: 40-69.
38. Oppermann M, Mack M, Proudfoot AE, Olbrich H, (1999) Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus. J Biol Chem 274: 8875-8885.
39. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, et al. (1996) Identification of a major co-receptor for primary isolates of HIV-1. Nature 381: 661-666.
40. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, et al. (1996) HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381: 667-673.
41. Benovic JL, Strasser RH, Caron MG, Lefkowitz RJ, (1986) Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor. Proc Natl Acad Sci U S A 83: 2797-2801.
42. Strasser RH, Benovic JL, Caron MG, Lefkowitz RJ, (1986) Beta-agonist- and prostaglandin E1-induced translocation of the beta-adrenergic receptor kinase: evidence that the kinase may act on multiple adenylate cyclase-coupled receptors. Proc Natl Acad Sci U S A 83: 6362-6366.
43. Morris GE, Nelson CP, Everitt D, Brighton PJ, Standen NB, et al. (2011) G protein-coupled receptor kinase 2 and arrestin2 regulate arterial smooth muscle P2Y-purinoceptor signalling. Cardiovasc Res 89: 193-203.
44. Shiina T, Arai K, Tanabe S, Yoshida N, Haga T, et al. (2001) Clathrin box in G protein-coupled receptor kinase 2. J Biol Chem 276: 33019-33026.
45. Freeman JL, Gonzalo P, Pitcher JA, Claing A, Lavergne JP, et al. (2002) Beta 2-adrenergic receptor stimulated, G protein-coupled receptor kinase 2 mediated, phosphorylation of ribosomal protein P2. Biochemistry 41: 12850-12857.
46. Gonzalo P, Reboud JP, (2003) The puzzling lateral flexible stalk of the ribosome. Biol Cell 95: 179-193.
47. Martinez-Azorin F, Remacha M, Ballesta JP, (2008) Functional characterization of ribosomal P1/P2 proteins in human cells. Biochem J 413: 527-534.
48. Remacha M, Jimenez-Diaz A, Bermejo B, Rodriguez-Gabriel MA, Guarinos E, et al. (1995) Ribosomal acidic phosphoproteins P1 and P2 are not required for cell viability but regulate the pattern of protein expression in Saccharomyces cerevisiae. Mol Cell Biol 15: 4754-4762.
49. Premont RT, Gainetdinov RR, (2007) Physiological roles of G protein-coupled receptor kinases and arrestins. Annu Rev Physiol 69: 511-534.